FDA Clearance Tracker · P860004-S275
SynchroMed Infusion System
Last checked: Nov 20, 2026Latest source record: Dec 21, 2017 (this decision)Source: openFDAMethods & limitations
Decided
Dec 21, 2017
Approved
Time to decision
238 days
Received Apr 27, 2017. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P860004-S275
- Device name
- SynchroMed Infusion System
- Applicant
- Medtronic, Inc.
- Applicant location
- Minneapolis, MN
- Received
- Apr 27, 2017
- Decided
- Dec 21, 2017
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P860004
Device type
- Device class
- Class III
- Specialty
- Hospital Medicine & Nursing
FDA's approval statement
As written in FDA's record.
Approval for changes made to the design history file and device master record of the motor component of the SynchroMed II Programmable Drug Infusion Pump (Model 8637), the associated parts of the motor (i.e. assemblies, subassemblies, components, subcomponents, and materials used in the manufacturing of the motor assembly), and the pumphead assembly material specifications.
Source documents
Other decisions for Medtronic, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K263596 · Decided Oct 29, 2026 · 29 days after receipt
Device type: Catheter, Cannula And Tubing, Vascular, Cardiopulmonary Bypass (DWF) · Cardiology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.